Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to take place in ...

No country in Europe is as much a product of enlightened postwar American diplomacy. Now adrift, it has begun to reckon with ...

-- Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an overall response rate of 91% and composite complete ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

Rhythm Pharmaceuticals received an orphan-drug designation from Japan's Ministry of Health, Labour and Welfare for its treatment for a certain type of obesity.

American travelers planning a European vacation dropped from 45% in 2024 to 37% in 2025, a staggering decline since 2021. The European Travel Commission, or ETC, reports cost as the main factor of ...

Attendees will gain insights into key market access, pricing and reimbursement challenges in Europe. The featured ... access opportunities If involved in orphan drug development, the attendees ...

The Latvian president has urged European countries to "absolutely" introduce conscription, as he conceded the continent was "quite weak" militarily. Edgars Rinkevics told Sky's Sunday Morning ...

European countries should “absolutely” be introducing conscription to combat the threat of Russian aggression, Latvian President Edgars Rinkēvičs said Sunday, as Europe grows increasingly ...

By Roger Cohen Reporting from Paris For decades a core objective of the Soviet Union was to “decouple” the United States from Europe. Decoupling, as it was called, would break the Western ...